ALB and COVID-19: [Albumin] is significantly decreased in severe cases of COVID-19 patients, including those requiring intensive care, by 10–20% and is considered an independent death risk factor linked to serious effects of the virus, such as coagulopathy, vascular disease and lung injury [44,76–79].